Multi-institutional study of the angiogenesis inhibitor TNP-470 in metastatic renal carcinoma.

Find People
Find Everything
About This Site
Edit My Profile
Export RDF
Login to Profiles

Multi-institutional study of the angiogenesis inhibitor TNP-470 in metastatic renal carcinoma.

Stadler WM, Kuzel T, Shapiro C, Sosman J, Clark J, Vogelzang NJ. Multi-institutional study of the angiogenesis inhibitor TNP-470 in metastatic renal carcinoma. J Clin Oncol. 1999 Aug; 17(8):2541-5.

View in: PubMed

subject areas

Adult
Aged
Aged, 80 and over
Angiogenesis Inhibitors
Carcinoma, Renal Cell
Combined Modality Therapy
Cyclohexanes
Disease-Free Survival
Female
Humans
Kidney Neoplasms
Male
Middle Aged
Neoplasm Metastasis
Sesquiterpenes

authors with profiles

Timothy Kuzel